BioHealth News Archive
Use this year’s angel investor rankings to place your startup – The American Genius
Look out Silicon Valley, there’s a new innovation hotbed in town. For the second year in a row, Central Texas Angel Network (CTAN) has…
Read More
AstraZeneca’s Imfinzi (durvalumab) Receives US FDA Accelerated Approval for Previously Treated Patients With Advanced Bladder Cancer
AstraZeneca (LSE: AZN) and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted accelerated…
Read More
Johns Hopkins seeding startups to keep health tech companies in Baltimore – DOTmed.com
Tired of seeing most of the $1 billion-plus it raised for startup funding leave the state, Johns Hopkins University has opened a new state-of-the-art…
Read MoreScience Advocates See Trump Backlash in Budget Boost – The Chronicle of Higher Education
If there was any doubt that a Republican-led Congress might give a strong boost to federal science spending, the Trump administration probably sealed the…
Read More
RFA-HL-17-023: Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R43/R44)
NHLBI small business awardees are eligible to apply for a competing revision to your current award. The Regenerative Medicine Innovation Project (RMIP), will support…
Read More
GSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD
GSK today announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for BENLYSTA® (belimumab) for…
Read More
NIH to get a $2 billion funding boost as Congress rebuffs Trump
The National Institutes of Health will get a $2 billion funding boost over the next five months, under a bipartisan spending deal reached late…
Read More
MaxBio Scientific Joins JHU Community – News – Johns Hopkins University Montgomery County Campus
For Charles Li, locating his office at the Johns Hopkins University Montgomery County Campus is like coming home. Li received his MBA from the…
Read More
Cerecor Reports Encouraging Topline Data from a NIH Sponsored Proof-of-Concept Trial of CERC-501 in Treatment-Resistant Depression
Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders,…
Read More
Jay Perman & Freeman Hrabowski: March for Science – Center Maryland Blog
On Saturday, hundreds of thousands of people are expected to march in Washington, DC, to celebrate and defend science—at a time when many believe…
Read More
VLP Therapeutics Receives Notice of Allowance of Key U.S. composition of matter Patent for immune checkpoint PD-1/PD-L1/PD-L2 inserted alphavirus VLP – VLP Therapeutics
VLP Therapeutics, LLC. (“VLP”), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines and antibody agents, today announced that…
Read More
Silver Spring-based United Therapeutics Corp. (NASDAQ: UTHR) partners with 3D Systems (NYSE: DDD) for human transplants – Washington Business Journal
Silver Spring-based United Therapeutics Corp. has been clear about its ambitions to build an unlimited supply of certain transplantable organs. Now, founder Martine Rothblatt…
Read More
Venture capital firms based in the Greater Washington, D.C. metro area are now competing with Silicon Valley-based venture capitalists to invest in D.C. companies – Washington Business Journal
The region has seen serious spikes in venture capital funding in the last decade — and more of our local firms are benefiting. …
Read More
RegeneRx Licensee Receives FDA Permission to Conduct a Phase 3 Trial of RGN-137 for Epidermolysis Bullosa in U.S. – Feb 27, 2017
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that…
Read More
Careers Opportunities at Personal Genome Diagnostics
PGDx launched in 2010 to bring innovative genetic analyses to cancer researchers, physicians and patients. PGDx uses cutting-edge next-generation sequencing and analysis techniques to…
Read More